Jan Wald Scientific Quotations

The price wasn't as important as clearing up some terms and conditions. If Boston Scientific has done that, then I don't know why Guidant's board wouldn't accept this bid.

I haven't heard from a single Guidant shareholder who doesn't like the Boston Scientific deal.

I think investors do take insider buying as a good sign, and I think they especially wanted Boston Scientific to do it.

Boston Scientific will do everything in its power to reach a deal with Guidant.

What the FDA seemed to be saying is that it doesn't know if Boston Scientific has a systemic, corporate-wide quality policy, and until it does the FDA will not permit the company to gain product approvals in adulterated plants.